| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | M01AH02 |
| UNII | 0QTW8Z7MCR |
| EPA CompTox | DTXSID2023567 |
| InChI Key | RZJQGNCSTQAWON-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H14O4S |
| Molecular Weight | 314.36 |
| AlogP | 2.56 |
| Hydrogen Bond Acceptor | 4.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 60.44 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 22.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Cyclooxygenase-2 inhibitor | INHIBITOR | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 71 | |
|
Enzyme
Oxidoreductase
|
- | 1-830 | - | - | -13-100 | |
|
Enzyme
|
- | 1-830 | - | - | -13-100 | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | -10.2-27.6 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 84.03-134.43 | |
|
Transporter
Primary active transporter
Oxidoreduction-driven transporters
|
- | 20 | - | - | - |
|
Protein: Cyclooxygenase-2 Description: Prostaglandin G/H synthase 2 Organism : Homo sapiens P35354 ENSG00000073756 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 8887 |
| ChEMBL | CHEMBL122 |
| DrugBank | DB00533 |
| DrugCentral | 2397 |
| FDA SRS | 0QTW8Z7MCR |
| Guide to Pharmacology | 2893 |
| KEGG | C07590 |
| PDB | RCX |
| PharmGKB | PA451268 |
| PubChem | 5090 |
| SureChEMBL | SCHEMBL3050 |
| ZINC | ZINC000000007455 |